Reactions 1704, p343 - 2 Jun 2018 Various toxicities: 8 case reports In a retrospective study, eight patients (five males and three females) [exact age at the time of reaction onset not stated] were described who developed who developed fever, vomiting, rash, diarrhoea, pain, oral mucositis/oral ulcer, increased alanine transaminase, increased aspartate aminotransferase or elevated total cholesterol during treatment with sirolimus [rapamycin; time to reaction onset not stated]. The patients had steroid-resistant vascular tumours with Kasabach–Merritt phenomenon. The patients started receiving oral sirolimus 0.8 mg/m two times daily at a intervals of 12 hours, at the age of ranging from 1 month to 20 months. The dose of sirolimus was adjusted to maintain the sirolimus level at 10-15 ng/mL. The duration of sirolimus treatment was 8-20 months. Subsequently, the patients developed grade 2 fever (two patients), grade 1/2 diarrhoea (two patients), grade 1 pain (one patient), grade 2 oral mucositis and ulcer (one patient), grade 1 vomiting and rash (one patient) and grade 1 increased alanine transaminase, grade 2 increased aspartate aminotransferase and grade 1 elevated total cholesterol (one patient). After symptomatic treatment, these side effects had resolved within two weeks. Author comment: "In the present study, analysed data are presented to support the use of sirolimus in clinical practise for the treatment of corticosteroid-resistant vascular tumours with KMP in eight infants." "Despite mild adverse reactions during the administration of sirolimus, the symptoms were generally alleviated after symptomatic treatment." Tan X, et al. Successful management of steroid-resistant vascular tumors associated with the Kasabach-Merritt phenomenon using sirolimus. Journal of Dermatology 45: 580-583, No. 5, 2018. Available from: URL: http:// doi.org/10.1111/1346-8138.14231 - China 803323550 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera